CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves.

Area of Science:

• Neuroscience
• Pain research
• Biochemistry

Background:

• Purinergic signaling, involving adenosine triphosphate (ATP) and adenosine, modulates pain in the nervous system.
• Ecto-nucleotidases regulate purinergic signaling by controlling ATP breakdown and adenosine production.
• Dysregulation of these enzymes is implicated in neuropathic pain.

Purpose of the Study:

• To investigate the presence and role of ecto-nucleotidases, specifically CD73, in the trigeminal pain pathway.
• To explore the potential contribution of CD73 to orofacial neuropathic pain.

Main Methods:

• Enzymatic histochemistry to detect ecto-AMPase activity.
• Immunofluorescence staining to confirm CD73 expression in trigeminal ganglia (TG) neurons and their projections.
• Assessment of CD73's effect on ecto-AMPase activity in the brainstem.

Main Results:

• Ecto-AMPase activity and CD73 expression were found in dental pulp, TG neurons, and their nerve fibers, including brainstem projections.
• CD73 and ecto-AMPase activity were present in the nociceptive lamina of the trigeminal subnucleus caudalis (TSNC).
• Anti-CD73 serum reduced ecto-AMPase activity in the TSNC, indicating CD73's functional role.

Conclusions:

• CD73 is expressed in the trigeminal nociceptive pathway and may modulate pain by influencing adenosine generation.
• Altered CD73 expression or localization in TG neurons could contribute to orofacial neuropathic pain.
• Targeting CD73 may offer therapeutic potential for neuropathic pain conditions.